Alliance for Clinical Trials in Oncology: Melanoma trials

The registry lists 13 Melanoma studies with Alliance for Clinical Trials in Oncology as lead sponsor. 1 are open to participants now and 6 have results posted.

Phase 1 2Phase 2 9Phase 3 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
• Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant MelanomaCompletedNCT00976573Phase 2Results posted
• Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by SurgeryCompletedNCT00626405Phase 2Results posted
• Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone MetastasesTerminatedNCT00540969Phase 3Results posted
• Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by SurgeryCompletedNCT00521001Phase 2Results posted
• Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00404235Phase 2Results posted
• Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic MelanomaCompletedNCT00060333Phase 2Results posted
• Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal MelanomaWithdrawnNCT05677373Phase 1/2
• Everolimus in Treating Patients With Stage IV MelanomaCompletedNCT00098553Phase 2
• Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous SystemTerminatedNCT00068666Phase 2
• Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II MelanomaCompletedNCT00049010Not applicable
• Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the LungCompletedNCT00017121Phase 1
• Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the LungCompletedNCT00005610Phase 2